Boehringer Ingelheim’s Formula For Scaling Transformation, Digitization
Boehringer Ingelheim’s corporate senior vice president, head of global regions, Timmo Rousku Andersen, outlines at a recent summit the company’s reshaped approach to digital innovation and the need to entrench an execution bias to scale transformation initiatives.
You may also be interested in...
Pharma may need to reorient its sales and marketing approach in India amid tighter regulatory scrutiny and growing digital adoption by physicians, opening up new opportunities for digital health startups to innovate across the commercialization value chain, indicates a leading venture capital firm.
Big pharma executives discuss the transformative potential of the metaverse in the life sciences segment and how things are shaping in the virtual world amid the hype. GSK’s senior VP and chief technology officer outlines to Scrip gains made deploying digital twins and bots.
Boehringer Ingelheim’s Head of Human Pharma Regions, Timmo Rousku Andersen shares with Scrip glimpses of his life and professional journey including distinct parallels between sports and leadership against the backdrop of the wider commercialization efforts for blockbuster therapy Jardiance.